| Onhealthcare | |
|
1200 Kirts Blvd, Suite 200, Troy, MI 48084-4899 | |
| (248) 528-1981 | |
| (614) 416-2105 |
| Full Name | Onhealthcare |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 1200 Kirts Blvd, Troy, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841429768 | NPI | - | NPPES |
| 03158418 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 005011 (New York) | Primary |
| 213E00000X | Podiatrist | 006416 (New York) | Secondary |
| Provider Name | Robert J Lloyd |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1942305818 PECOS PAC ID: 1052467750 Enrollment ID: I20090922000494 |
News Archive
Philanthropy just got easier and a lot more accessible to the public thanks to the social networking power of the Internet and a ground-breaking partnership between a young British entrepreneur, a global health think tank and an African medical research institute.
Genentech, Inc. a wholly-owned member of the Roche Group, and Biogen Idec announced today that the companies received a Complete Response from the U.S. Food and Drug Administration (FDA) for a supplemental Biologics License Application (sBLA) for Rituxan (rituximab) plus methotrexate (MTX) in patients with moderately-to-severely active rheumatoid arthritis (RA) who no longer respond to treatment with a disease modifying antirheumatic drug (DMARD), including MTX.
The Department of Health and Human Services is touting a partnership with major retail pharmacies to tell seniors about health law benefits.
Leading scientists have identified an important gene that is associated with cleft lip and palate.Experts say the discovery is a step closer to understanding how this birth defect arises, and will help in the development of medical approaches to prevent the disfiguring condition.
› Verified 3 days ago
| Provider Name | Andrew Feltz |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1225037393 PECOS PAC ID: 4880668235 Enrollment ID: I20110609000010 |
News Archive
Philanthropy just got easier and a lot more accessible to the public thanks to the social networking power of the Internet and a ground-breaking partnership between a young British entrepreneur, a global health think tank and an African medical research institute.
Genentech, Inc. a wholly-owned member of the Roche Group, and Biogen Idec announced today that the companies received a Complete Response from the U.S. Food and Drug Administration (FDA) for a supplemental Biologics License Application (sBLA) for Rituxan (rituximab) plus methotrexate (MTX) in patients with moderately-to-severely active rheumatoid arthritis (RA) who no longer respond to treatment with a disease modifying antirheumatic drug (DMARD), including MTX.
The Department of Health and Human Services is touting a partnership with major retail pharmacies to tell seniors about health law benefits.
Leading scientists have identified an important gene that is associated with cleft lip and palate.Experts say the discovery is a step closer to understanding how this birth defect arises, and will help in the development of medical approaches to prevent the disfiguring condition.
› Verified 3 days ago
| Provider Name | Scott Jason Giaimo |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1912967381 PECOS PAC ID: 2163488446 Enrollment ID: I20120216000006 |
News Archive
Philanthropy just got easier and a lot more accessible to the public thanks to the social networking power of the Internet and a ground-breaking partnership between a young British entrepreneur, a global health think tank and an African medical research institute.
Genentech, Inc. a wholly-owned member of the Roche Group, and Biogen Idec announced today that the companies received a Complete Response from the U.S. Food and Drug Administration (FDA) for a supplemental Biologics License Application (sBLA) for Rituxan (rituximab) plus methotrexate (MTX) in patients with moderately-to-severely active rheumatoid arthritis (RA) who no longer respond to treatment with a disease modifying antirheumatic drug (DMARD), including MTX.
The Department of Health and Human Services is touting a partnership with major retail pharmacies to tell seniors about health law benefits.
Leading scientists have identified an important gene that is associated with cleft lip and palate.Experts say the discovery is a step closer to understanding how this birth defect arises, and will help in the development of medical approaches to prevent the disfiguring condition.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Onhealthcare 1200 Kirts Blvd, Suite 200, Troy, MI 48084-4899 Ph: (248) 528-1981 | Onhealthcare 1200 Kirts Blvd, Suite 200, Troy, MI 48084-4899 Ph: (248) 528-1981 |
News Archive
Philanthropy just got easier and a lot more accessible to the public thanks to the social networking power of the Internet and a ground-breaking partnership between a young British entrepreneur, a global health think tank and an African medical research institute.
Genentech, Inc. a wholly-owned member of the Roche Group, and Biogen Idec announced today that the companies received a Complete Response from the U.S. Food and Drug Administration (FDA) for a supplemental Biologics License Application (sBLA) for Rituxan (rituximab) plus methotrexate (MTX) in patients with moderately-to-severely active rheumatoid arthritis (RA) who no longer respond to treatment with a disease modifying antirheumatic drug (DMARD), including MTX.
The Department of Health and Human Services is touting a partnership with major retail pharmacies to tell seniors about health law benefits.
Leading scientists have identified an important gene that is associated with cleft lip and palate.Experts say the discovery is a step closer to understanding how this birth defect arises, and will help in the development of medical approaches to prevent the disfiguring condition.
› Verified 3 days ago
Sandra Shina Hou, OD Optometrist Medicare: Medicare Enrolled Practice Location: 2001 W Maple Rd, Wal Mart Vision Center, Troy, MI 48084 Phone: 248-435-4126 Fax: 248-435-4162 | |
Svs Vision Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 6828 Rochester Rd, Troy, MI 48085 Phone: 248-710-1100 Fax: 248-786-2928 | |
Andrea M. Langolf, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 2877 Crooks Rd, Ste B, Troy, MI 48084 Phone: 248-822-7003 Fax: 248-822-7008 | |
Sasha Shammami Kashat, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1301 Coolidge Hwy, Troy, MI 48084 Phone: 248-643-9880 | |
Dr. Rhonda Elisha Thompson, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 735 John R Rd, Troy, MI 48083 Phone: 248-951-0000 Fax: 248-528-4040 | |
Dr. Bruce Richard Wolffis, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 735 John R Rd Ste 150, Troy, MI 48083 Phone: 248-577-3659 Fax: 248-588-9917 | |
Dr. Timothy Schrot, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 506 W 14 Mile Rd, Troy, MI 48083 Phone: 248-589-8240 Fax: 248-589-2597 |